[Effect of antianginal agents with a beta-adrenostimulating component of their action on the ischemic myocardium]. 1982

N V Kaverina, and G G Chichkanov, and A K Bogolepov, and T N Azvolinskaia, and D D Matsievskiĭ

Experiments on dogs with acute coronary insufficiency were made to show that nonachlazine in doses of 3 and 5 mg/kg considerably reduces or even prevents the rise of S-T segment on the epicardial electrogram depending on the intensity of ischemia. Hydroxyfedrine in doses of 0.1 and 0.3 mg/kg deteriorates the electrogram. Nonachlazine prevents an increase in the content of lactate and in the lactate/pyruvate ratio in the blood outflowing from the focus of ischemia. On the contrary, hydroxyfedrine raises the characteristics in question. Nonachlazine improves blood supply of the ischemized myocardium, increases the retrograde coronary blood flow and redistributes blood in favour of the affected myocardial area. Hydroxyfedrine lowers the retrograde blood supply of the area of ischemia and redistributes blood in favour of the unaffected areas of the heart.

UI MeSH Term Description Entries
D009628 Nonachlazine Coronary vasodilator with a novel mechanism of action; proposed as antianginal agent. Azaclorzine,Nonachlazin,Nonakhlazin
D010099 Oxyfedrine A drug used in the treatment of angina pectoris, heart failure, conduction defects, and myocardial infarction. It is a partial agonist at beta adrenergic receptors and acts as a coronary vasodilator and cardiotonic agent. Oxyphedrin,Ildamen,Myofedrin,Oxifedrine,Oxiphedrin
D010640 Phenothiazines Compounds containing dibenzo-1,4-thiazine. Some of them are neuroactive.
D011427 Propiophenones Propiophenone (ethyl phenyl ketone, structural formula C6H5COCH2CH3) and its derivatives. They are commonly used in perfumes and pharmaceuticals.
D003326 Coronary Circulation The circulation of blood through the CORONARY VESSELS of the HEART. Circulation, Coronary
D003327 Coronary Disease An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. Coronary Heart Disease,Coronary Diseases,Coronary Heart Diseases,Disease, Coronary,Disease, Coronary Heart,Diseases, Coronary,Diseases, Coronary Heart,Heart Disease, Coronary,Heart Diseases, Coronary
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004353 Drug Evaluation, Preclinical Preclinical testing of drugs in experimental animals or in vitro for their biological and toxic effects and potential clinical applications. Drug Screening,Evaluation Studies, Drug, Pre-Clinical,Drug Evaluation Studies, Preclinical,Drug Evaluations, Preclinical,Evaluation Studies, Drug, Preclinical,Evaluation, Preclinical Drug,Evaluations, Preclinical Drug,Medicinal Plants Testing, Preclinical,Preclinical Drug Evaluation,Preclinical Drug Evaluations,Drug Screenings,Screening, Drug,Screenings, Drug
D004562 Electrocardiography Recording of the moment-to-moment electromotive forces of the HEART as projected onto various sites on the body's surface, delineated as a scalar function of time. The recording is monitored by a tracing on slow moving chart paper or by observing it on a cardioscope, which is a CATHODE RAY TUBE DISPLAY. 12-Lead ECG,12-Lead EKG,12-Lead Electrocardiography,Cardiography,ECG,EKG,Electrocardiogram,Electrocardiograph,12 Lead ECG,12 Lead EKG,12 Lead Electrocardiography,12-Lead ECGs,12-Lead EKGs,12-Lead Electrocardiographies,Cardiographies,ECG, 12-Lead,EKG, 12-Lead,Electrocardiograms,Electrocardiographies, 12-Lead,Electrocardiographs,Electrocardiography, 12-Lead

Related Publications

N V Kaverina, and G G Chichkanov, and A K Bogolepov, and T N Azvolinskaia, and D D Matsievskiĭ
January 1983, Advances in myocardiology,
N V Kaverina, and G G Chichkanov, and A K Bogolepov, and T N Azvolinskaia, and D D Matsievskiĭ
January 1996, Eksperimental'naia i klinicheskaia farmakologiia,
N V Kaverina, and G G Chichkanov, and A K Bogolepov, and T N Azvolinskaia, and D D Matsievskiĭ
January 1984, Japanese circulation journal,
N V Kaverina, and G G Chichkanov, and A K Bogolepov, and T N Azvolinskaia, and D D Matsievskiĭ
September 1987, Japanese heart journal,
N V Kaverina, and G G Chichkanov, and A K Bogolepov, and T N Azvolinskaia, and D D Matsievskiĭ
October 1990, Kardiologiia,
N V Kaverina, and G G Chichkanov, and A K Bogolepov, and T N Azvolinskaia, and D D Matsievskiĭ
January 1987, Journal of cardiovascular pharmacology,
N V Kaverina, and G G Chichkanov, and A K Bogolepov, and T N Azvolinskaia, and D D Matsievskiĭ
July 1966, American heart journal,
N V Kaverina, and G G Chichkanov, and A K Bogolepov, and T N Azvolinskaia, and D D Matsievskiĭ
January 2016, Cardiology in review,
N V Kaverina, and G G Chichkanov, and A K Bogolepov, and T N Azvolinskaia, and D D Matsievskiĭ
January 1992, Eksperimental'naia i klinicheskaia farmakologiia,
N V Kaverina, and G G Chichkanov, and A K Bogolepov, and T N Azvolinskaia, and D D Matsievskiĭ
January 1992, Kardiologiia,
Copied contents to your clipboard!